IP Library Granted Patent US 12,297,161
Granted Patent B2
US 12,297,161 · App. 17/043,017 · Granted May 13, 2025

Process for making sarecycline hydrochloride

Inventors: Giovanni Palombi (Monza, IT); Eugenio Castelli (Arlate, IT); Giuseppe Motta (Rescaldina, IT); Meinrad Brenner (Steg, CH); Ruiliang Lu (Guangzhou, CN); Shaozhi Huang (Foshan, CN); William Paul Armstrong (Carrickfergus, GB); Gajanan Joshi (South Plainfield, NJ); Farzaneh Seyedi (Boston, MA); Sean Johnston (Boston, MA)
Assignee: ALMIRALL, LLC
C07C231/12C07C237/26C07C2603/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,297,161
App. No.
17/043,017
Granted
May 13, 2025
Kind
B2
Abstract

The described invention relates to sarecycline, related compounds, intermediates and salts thereof and processes for preparing the same.

Claims (61)

1. A process for preparing sarecycline hydrochloride of Formula (I)

comprising:

(a) reacting (4S,4aS,5aR,12aR)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-3, 12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide of Formula II

with

(i) trifluoroacetic acid (TFA); and

(ii) N-iodosuccinimide (NIS);

to form 7-iodosancycline trifluoroacetic acid salt of Formula III

b) reacting the 7-iodosancycline trifluoroacetic acid salt of Formula (III) with

(i) N-methyl pyrrolidone (NMP);

(ii) triphenylphosphine (PPh 3 );

(iii) Bis-(Triphenyl Phosphine) palladium chloride catalyst (BTPP—PdCl 2 );

(iv) triethylsilane (Et 3 SiH); and

(v) carbon monoxide (CO);

to form 7-formylsancycline of Formula IV

c) reacting the 7-formylsancycline of Formula IV with

(i) dimethylhydroxylamine (DMHA) free base;

(ii) oxalic acid;

(iii) dimethylaminoborane (DMAB); and

(iv) acetone

to form sarecycline crude oxalate salt of Formula V

d) reacting the sarecycline crude oxalate salt of Formula V with

(i) ammonium hydroxide (NH 3 (aqueous)) or hydrochloride acid (HCl);

to form sarecycline free base of Formula VI

(e) reacting the sarecycline free base of Formula VI with

(i) ethanolic hydrochloric acid solution

to form the sarecycline hydrochloride of Formula I.

2. The process according to claim 1 , wherein step (a) further comprises

i. isopropanol; or

ii. tetrahydrofuran (THF); or

iii. isopropanol and tetrahydrofuran (THF).

3. The process according to claim 1 , wherein step (b) further comprises

i. cellulose or SiO 2 ; or

ii. sodium carbonate (Na 2 CO 3 ); or

iii. water; or

iv. sulfuric acid (H 2 SO 4 ); or

V. ethanol (EtOH); or

vi. a combination thereof.

4. The process according to claim 1 , wherein step (c) further comprises methanol (MeOH).

5. The process according to claim 1 , wherein step (d) further comprises

i. cellulose or SiO 2 ; or

ii. dichloromethane (DCM); or

iii. water; or

iv. methanol (MeOH); or

V. acetone; or

vi. a combination thereof.

6. The process according to claim 1 , wherein step (e) further comprises

i. ethanol (EtOH); or

ii. water; or

iii. hydrochloric acid (HCl); or

iv. a combination thereof.

7. The process according to claim 1 , wherein step (d) is repeated at least one time.

8. The process according to claim 1 , further comprising:

(d′) reacting the sarecycline free base of Formula VI with

(i) trifluoroacetic acid (TFA); and

(ii) tetrahydrofuran (THF)

and repeating steps (d) and (e).

9. The process according to claim 8 , wherein step (d′) further comprises

i. water; or

ii. isopropanol; or

iii. water and isopropanol.

10. The process according to claim 8 , wherein steps (d′) and (d) are repeated at least one time.

Assignments (3)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 065001/0917 Recorded May 22, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 071343/0407 →
SECURITY INTEREST Recorded Sep 22, 2023
From: PARATEK PHARMACEUTICALS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 065001/0917 →
ASSIGNEE CHANGE OF ADDRESS Recorded Mar 9, 2023
From: ALMIRALL, LLC
To: ALMIRALL, LLC
Reel/Frame 063012/0949 →